Filter
220
Text search:
FDA
Featured
Recommendations
21
New Publications
30
Language
Document type
No document type
103
Guidelines
63
Studies & Reports
27
Manuals
7
Fact sheets
7
Strategic & Response Plan
6
Training Material
4
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
8
Russia
8
Latin America and the Carribbean
7
Ghana
6
Philippines
4
Syria
4
South Africa
4
Ecuador
4
Uganda
3
Sudan
3
Yemen
3
Middle East and North Africa
3
South–East Asia Region
3
Western and Central Europe
3
Eastern Europe
3
Congo, Democratic Republic of
2
USA
2
Ethiopia
2
South Sudan
2
Brazil
2
Colombia
2
Myanmar / Burma
2
Asia
2
Global
2
Nigeria
1
Zimbabwe
1
Iraq
1
Jordan
1
Germany
1
Kenya
1
Tanzania
1
Thailand
1
Argentina
1
Bolivia
1
Chile
1
Paraguay
1
Africa
1
Venezuela
1
Kazakhstan
1
France
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
57
Clinical Guidelines
26
Pharmacy & Technologies
12
Women & Child Health
5
Public Health
4
Key Resources
3
Toolboxes
COVID-19
47
Mental Health
30
TB
25
HIV
22
Pharmacy
13
AMR
12
Specific Hazards
7
Ebola & Marburg
4
Rapid Response
4
Planetary Health
4
NTDs
4
Refugee
3
NCDs
3
Malaria
2
2.0 Rapid Response
2
Cholera
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
O presente documento fornece orientações aos Estados-Membros da União Africana com base num pedido específico dos Estados-Membros de uma lista de controlo/orientação dos equipamentos de protecção individual (EPI) necessários aos profissionais de saúde e prestadores de cuidados para a pande
...
Principles and Target Product Criteria. Roadmap January 12, 2015
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults,
...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Improve identification, verification, communication and coordination.
PLoS Negl Trop Dis 14(1): e0007999. January 30, 2020 is the first-ever World Neglected Tropical Diseases Day (World NTD Day), a day when we celebrate the achievements made towards control of the world’s NTDs, yet recognize the daunting challenges we face in the control and elimination of these con
...
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a
...
Le trouble anxiété de séparation (TAS) représente environ la moitié de l’ensemble des troubles anxieux
(Cartwright-Harton et al, 2006). La plupart des troubles anxieux pédiatriques
présentent les mêmes critères diagnostics que chez l’adulte à l’exception du TAS,
actuellement class
...
WHO Medical Devices Donations - SPANISH Version - Las tecnologías sanitarias son fundamentales en un sistema de salud operativo. Los dispositivos médicos, en concreto, son cruciales para la prevención, el diagnóstico, el tratamiento y la rehabilitación de enfermedades. Estos documentos están d
...
Standard Treatment Guideline
Morbidity and Mortality Weekly Report
Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9
